3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Classical hematology
9
Gynecologic
4
Breast
4
Gastrointestinal
3
Genitourinary
1
Conditions
Prostatic Neoplasms
1214
Urinary Bladder Neoplasms
386
Carcinoma, Renal Cell
329
Kidney Neoplasms
205
Neoplasms
157
Breast Neoplasms
146
Lung Neoplasms
101
Carcinoma, Transitional Cell
99
Colorectal Neoplasms
77
Testicular Neoplasms
74
Ovarian Neoplasms
62
Melanoma
60
Pancreatic Neoplasms
57
Colonic Neoplasms
50
Carcinoma, Non-Small-Cell Lung
50
Head and Neck Neoplasms
47
Stomach Neoplasms
45
Non-Muscle Invasive Bladder Neoplasms
45
Disease
45
Neoplasm Metastasis
41
Liver Neoplasms
40
Uterine Cervical Neoplasms
39
Esophageal Neoplasms
37
Wilms Tumor
36
Prostatic Hyperplasia
36
Adenocarcinoma
33
Multiple Myeloma
32
Urologic Neoplasms
30
Sarcoma
30
Recurrence
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Fanconi Anemia, Complementation Group D1
×
Genitourinary
×
Clear all
NCT04425200
2021-12-07
ZENSHIN
AstraZeneca
Completed
205 enrolled